Mperia Therapeutics is the CD36 Therapeutics Development Company. Lead candidates applied to macrophage-driven inflammation via CD36 receptor immuno-metabolism mediation. Showing clear efficacy in pre-clinical models for dry age-related macular degeneration (dry AMD), atherosclerosis and NASH.
Company Details
- Founded
- -
- Address
- 1 Westmount Sq, Montreal,quebec H3z,canada
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- mperiathera.com
- HQ
- Montreal, Quebec
Mperia Therapeutics Inc Questions
Mperia Therapeutics Inc's website is mperiathera.com
Mperia Therapeutics Inc's LinkedIn profile is https://ca.linkedin.com/company/mperia-therapeutics-inc
Mperia Therapeutics Inc's industry is
Biotechnology Research
Mperia Therapeutics Inc's top competitors are
Neuropresse,
Urodev,
The Translational Scientist,
Textgenetic Ai Inc.,
Cerno Health,
Myx Therapeutics,
Taris Biomedical Llc,
Mmsense Technologies Inc.,
Stemaxon,
Matrix Innovation Inc..
Mperia Therapeutics Inc's categories are Biotechnology Research
Mperia Therapeutics Inc's founding year is 2016
